HIV molecular immunology database


Patient Detail

Patient Code 8183A
Patient Sex Male
Risk Factor
Infection Country
Infection City
Infection Year
HLA Type A*02:01, A*03:01, B*35:01, B*51, C*04, C*06
Patient Ethnicity
Progression Progressor (P)
Species human
Patient Note Acutely infected Patient 8183A subsequently discontinued ART. Infection was detected in this patient 45 days following onset of symptoms; he began ART immediately and was followed longitudinally over a 4-year period. His plasma viral load (VL) became undetectable on ART (lamivudine, indinavir, nelfinavir and zalcitabine). Therapy was discontinued after 10 months when ART-related lactic acidosis developed. He remained ART-free for >2 years until surrogate markers of disease progression necessitated reinstitution of ART [plasma viral load of 157 589 copies/ml and CD4 cell count of 322 x 106,/sup>/l 40 months post-onset of acute retroviral symptoms (POARS). At 3 months POARS, the T-cell response of 8183A was narrowly directed to CD8 T-cell epitopes in Vif and Nef. The two epitopes in Vif were determined to be restricted by HLA-B*51. T-cell responses of 8183A at 49 months were reduced in frequency and appeared to be waning while he was on potent ART
CTL CD8+ Records 53596, 53597, 53599, 53600, 53602, 53603, 53604, 53605, 53606, 53607, 53608, 53609, 53610
T-Helper CD4+ Records
Antibody Records
Sequence Database Patient ID Record
Questions or comments? Contact us at
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health